Trending News
News
News
A Cluster of Dopamine Neurons Drive Our Eating Behaviours
Researchers has revealed new insights into the role our brains play in why we vigorously seek food when we are hungry, knowledge that may enhance understanding of obesity and eating disorders.
News
Why Does Red Wine Give Some People Headaches?
For some people, drinking red wine even in small amounts causes a headache. In a new study, scientists at the University of California, Davis, examined why this happens
News
Adding Soap Boosts Pesticide Effectiveness
Researchers have found that adding small quantities of liquid soap to some classes of pesticides can boost their potency. The discovery is promising news as malaria-carrying mosquitoes display an increasing resistance to current insecticides
News
What Is the New Weight Loss Drug Zepbound, and Why Has It Been Approved?
The US Food and Drug Administration (FDA) has approved Zepbound™ (tirzepatide) for use in conjunction with a reduced-calorie diet and increased exercise to help obese adults manage their bodyweight.
News
Novel Pill-Sized Device Can Monitor Breathing From the Gut
Scientists have developed an ingestible device that can safely monitor vital signs like breathing and heart rate from inside humans. The tool has the potential to provide accessible and convenient care for people at risk of opioid overdose.
News
Antibody Turbocharges the Immune System Against Cancer
A new study has identified an antibody that can supercharge the immune system, helping to overcome a previously unknown mechanism by which cancer cells prevent phagocytosis.
News
Molecular Glue Degraders Could Target “Undruggable” Proteins
Cells contain molecular machinery that targets and disposes of unwanted proteins. Scientists would like to hijack this process to control proteins involved in cancer and other diseases, using a type of molecule called a molecular glue degrader.
News
Cancer Immunotherapy Shows Promise Against Tuberculosis
A promising new cancer therapy also appears extremely potent against one of the world’s most devastating infectious diseases: tuberculosis (TB). Scientists found the therapy dramatically reduces TB growth, even for bacteria that are drug-resistant.
News
Genomic "Tug of War" Could Influence How Cancer Patients Respond to Decitabine
A genomic tug of war for a gene activator could explain why some cancers respond to decitabine and others don't respond or become resistant over time.
News
Hormone Therapy May Be Potential Treatment for Liver Fibrosis
Researchers have discovered previously unknown changes in a specific type of liver cells, potentially opening avenues for a new treatment for liver fibrosis, a potentially life-threatening condition.
Advertisement